Oracle Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Oracle Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-350,000	Closed	-$1.08M	–	34
2021 Q4	$1.08M	Buy	+350,000	New	+$24.2M	0.15%	22

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Oracle Investment Management's ARKG Position: Q4 2025 in Review

Oracle Investment Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q4 2025: 19,500 shares worth $565K. The stake represents 0.34% of the portfolio and ranks #17 among its holdings.

238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Oracle Investment Management held 19,500 shares of ARK Genomic Revolution ETF worth $565K as of Q4 2025.
ARK Genomic Revolution ETF was a new Oracle Investment Management position in Q4 2025.
ARK Genomic Revolution ETF made up 0.34% of Oracle Investment Management's portfolio in Q4 2025, its #17 holding.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.